These results demonstrate that propofol can function as a tumor suppressor in cancer through miRNA, JAK2/STAT3, RAP1/NF-κB, PTEN/AKT, and ERK1/2 signaling pathways. The gene discussed is AKT1; the disease is neoplasm.